News Releases

Regeneus trebles on back of merger deal (Sydney Morning Herald)

Apr 5, 2024

Cambium Bio to enter ASX through backdoor listing via merger with Regeneus to treat dry eye disease

Feb 6, 2024

Back to Investors and Media